9-35700020-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006289.4(TLN1):c.6722G>A(p.Arg2241Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,613,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2241W) has been classified as Uncertain significance.
Frequency
Consequence
NM_006289.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152062Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000319 AC: 8AN: 251086 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461386Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 726900 show subpopulations
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74272 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.6722G>A (p.R2241Q) alteration is located in exon 50 (coding exon 49) of the TLN1 gene. This alteration results from a G to A substitution at nucleotide position 6722, causing the arginine (R) at amino acid position 2241 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at